Skip to main content

Table 2 Unadjusted and adjusted Cox proportional hazard analysis for overall survival

From: Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

Overall survival

         
 

Unadjusted model

Overall cohort

Large adjusted model

Overall cohort

Simple adjusted model

Overall cohort

 

HR

95% CI

p

HR

95% CI

p

HR

95% CI

p

MCT1

1.622

1.030–2.554

0.037

2.123

1.145–3.937

0.017

1.963

1.199–3.214

0.007

Grade

4.684

1.715–12.79

0.003

3.210

1.136–9.076

0.028

3.797

1.372–10.50

0.010

Stage

2.288

1.500–3.489

<0.001

1.965

1.078–3.579

0.027

2.080

1.300–3.328

0.002

Size

1.269

0.585–2.750

0.547

0.681

0.306–1.515

0.346

LVSI

2.347

0.935–5.891

0.069

1.185

0.378–3.718

0.771

MI

1.447

0.609–3.436

0.403

1.121

0.340–3.690

0.851

  1. Grade categorised as Grade I/II and III tumours; Stage: FIGO 2009 stage categorised as 1, 2, 3 and 4; Size categorised as <2 cm, between 2 and 5 cm and bigger than 5 cm; LVSI: Lymphovascular space involvement categorised as “Yes” and “No”; MI: Depth of myometrial invasion categorised as <50% and more than 50%; HR: hazard ratio, CI: confidence interval. Bold text indicates statistically significant data at p < 0.05 level